Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Eight-week, Multinational, Multicenter, Double-blind, Active- and Placebo-controlled Clinical Trial Evaluating the Efficacy and Tolerability of Three Fixed Doses of SSR125543 (20 mg Daily, 50 mg Daily and 100 mg Daily) in Outpatients With Major Depressive Disorder

NCT01034995 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01034995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01034995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Eight-week, Multinational, Multicenter, Double-blind, Active- and Placebo-controlled Clinical Trial Evaluating the Efficacy and Tolerability of Three Fixed Doses of SSR125543 (20 mg Daily, 50 mg Daily and 100 mg Daily) in Outpatients With Major Depressive Disorder
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2010
Completion date
March 31, 2011
Enrollment
580 (estimated)
Sites
73

Conditions

As the registry lists them; a condition with its own page is linked.

major depression